Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Imagin Medical Inc (IME.CN)

Imagin Medical Inc (IME.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Imagin Medical Inc 890 West Pender Street Suite 600 Vancouver BC V6C 1J9 CAN

https://www.imaginmedical.com P: 833-246-2446 F: 604-687-1327

Description:

Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.

Key Statistics

Overview:

Market Capitalization, $K 162
Shares Outstanding, K 10,830
Annual Sales, $ 0 K
Annual Net Income, $ -2,492 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -873 K
60-Month Beta 1.43
% of Institutional Shareholders 54.25%

Growth:

1-Year Return -93.62%
3-Year Return -96.51%
5-Year Return -99.32%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -93.55%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/27/20

IME.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -70.77%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -1.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar